Amarin Corporation PLC (NASDAQ:AMRN)

2.88
Delayed Data
As of Jun 22
 -0.12 / -4.00%
Today’s Change
2.66
Today|||52-Week Range
4.60
-28.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$942.4M

Company Description

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It's product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Contact Information

Amarin Corp. Plc
2 Pembroke House
Dublin Dublin 2
P:(531) 669-9020
Investor Relations:

Employees

Shareholders

Mutual fund holders7.95%
Other institutional33.46%
Individual stakeholders2.90%

Top Executives

John F. TheroPresident, Chief Executive Officer & Director
Derek KalinowskiSVP-Manufacturing Operations
Michael W. KalbCFO, Principal Accounting Officer & Senior VP
Steven B. KetchumChief Scientific Officer & Senior Vice President
Craig B. GranowitzChief Medical Officer